EMEA (Europe, Middle East and Africa) Sorafenib Market Report 2017

December 2017 | 110 pages | ID: E58D05ED445EN
QYResearch

Abstracts

In this report, the EMEA Sorafenib market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Sorafenib for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Sorafenib market competition by top manufacturers/players, with Sorafenib sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pfizer
• Allergan
• Alnylam Pharmaceuticals
• Acceleron Pharma
• Biocon
• Bionomics
• CASI Pharmaceuticals
• Celgene Corporation
• Enzon Pharmaceuticals
• Five Prime Therapeutics
• Fujifilm Kyowa Kirin Biologics
• Genentech
• Genexine
• Hetero Drugs
• ImClone Systems
• Intas Pharmaceuticals
• Levolta Pharmaceuticals
• Mabtech

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Capsule
• Tablet

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Sorafenib Market Report 2017

1 SORAFENIB OVERVIEW

1.1 Product Overview and Scope of Sorafenib
1.2 Classification of Sorafenib
  1.2.1 EMEA Sorafenib Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Sorafenib Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Capsule
  1.2.4 Tablet
1.3 EMEA Sorafenib Market by Application/End Users
  1.3.1 EMEA Sorafenib Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospital Pharmacy
  1.3.3 Retail Pharmacy
  1.3.4 Online Pharmacy
1.4 EMEA Sorafenib Market by Region
  1.4.1 EMEA Sorafenib Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Sorafenib (2012-2022)
  1.5.1 EMEA Sorafenib Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Sorafenib Revenue and Growth Rate (2012-2022)

2 EMEA SORAFENIB COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Sorafenib Market Competition by Players/Manufacturers
  2.1.1 EMEA Sorafenib Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Sorafenib Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Sorafenib Sale Price by Players (2012-2017)
2.2 EMEA Sorafenib (Volume and Value) by Type/Product Category
  2.2.1 EMEA Sorafenib Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Sorafenib Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Sorafenib Sale Price by Type (2012-2017)
2.3 EMEA Sorafenib (Volume) by Application
2.4 EMEA Sorafenib (Volume and Value) by Region
  2.4.1 EMEA Sorafenib Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Sorafenib Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Sorafenib Sales Price by Region (2012-2017)

3 EUROPE SORAFENIB (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Sorafenib Sales and Value (2012-2017)
  3.1.1 Europe Sorafenib Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Sorafenib Revenue and Growth Rate (2012-2017)
3.2 Europe Sorafenib Sales and Market Share by Type
3.3 Europe Sorafenib Sales and Market Share by Application
3.4 Europe Sorafenib Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Sorafenib Sales Volume by Countries (2012-2017)
  3.4.2 Europe Sorafenib Revenue by Countries (2012-2017)
  3.4.3 Germany Sorafenib Sales and Growth Rate (2012-2017)
  3.4.4 France Sorafenib Sales and Growth Rate (2012-2017)
  3.4.5 UK Sorafenib Sales and Growth Rate (2012-2017)
  3.4.6 Russia Sorafenib Sales and Growth Rate (2012-2017)
  3.4.7 Italy Sorafenib Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Sorafenib Sales and Growth Rate (2012-2017)

4 MIDDLE EAST SORAFENIB (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Sorafenib Sales and Value (2012-2017)
  4.1.1 Middle East Sorafenib Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Sorafenib Revenue and Growth Rate (2012-2017)
4.2 Middle East Sorafenib Sales and Market Share by Type
4.3 Middle East Sorafenib Sales and Market Share by Application
4.4 Middle East Sorafenib Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Sorafenib Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Sorafenib Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Sorafenib Sales and Growth Rate (2012-2017)
  4.4.4 Israel Sorafenib Sales and Growth Rate (2012-2017)
  4.4.5 UAE Sorafenib Sales and Growth Rate (2012-2017)
  4.4.6 Iran Sorafenib Sales and Growth Rate (2012-2017)

5 AFRICA SORAFENIB (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Sorafenib Sales and Value (2012-2017)
  5.1.1 Africa Sorafenib Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Sorafenib Revenue and Growth Rate (2012-2017)
5.2 Africa Sorafenib Sales and Market Share by Type
5.3 Africa Sorafenib Sales and Market Share by Application
5.4 Africa Sorafenib Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Sorafenib Sales Volume by Countries (2012-2017)
  5.4.2 Africa Sorafenib Revenue by Countries (2012-2017)
  5.4.3 South Africa Sorafenib Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Sorafenib Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Sorafenib Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Sorafenib Sales and Growth Rate (2012-2017)

6 EMEA SORAFENIB MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Sorafenib Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Allergan
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Sorafenib Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Allergan Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Alnylam Pharmaceuticals
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Sorafenib Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Alnylam Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Acceleron Pharma
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Sorafenib Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Acceleron Pharma Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Biocon
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Sorafenib Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Biocon Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Bionomics
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Sorafenib Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Bionomics Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 CASI Pharmaceuticals
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Sorafenib Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 CASI Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Celgene Corporation
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Sorafenib Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Celgene Corporation Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Enzon Pharmaceuticals
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Sorafenib Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Enzon Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Five Prime Therapeutics
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Sorafenib Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Five Prime Therapeutics Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Fujifilm Kyowa Kirin Biologics
6.12 Genentech
6.13 Genexine
6.14 Hetero Drugs
6.15 ImClone Systems
6.16 Intas Pharmaceuticals
6.17 Levolta Pharmaceuticals
6.18 Mabtech

7 SORAFENIB MANUFACTURING COST ANALYSIS

7.1 Sorafenib Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Sorafenib

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Sorafenib Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Sorafenib Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA SORAFENIB MARKET FORECAST (2017-2022)

11.1 EMEA Sorafenib Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Sorafenib Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Sorafenib Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Sorafenib Price and Trend Forecast (2017-2022)
11.2 EMEA Sorafenib Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Sorafenib Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Sorafenib Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Sorafenib Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Sorafenib Sales Forecast by Type (2017-2022)
11.7 EMEA Sorafenib Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Sorafenib
Figure EMEA Sorafenib Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Sorafenib Sales Volume Market Share by Type (Product Category) in 2016
Figure Capsule Product Picture
Figure Tablet Product Picture
Figure EMEA Sorafenib Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Sorafenib by Application in 2016
Figure Hospital Pharmacy Examples
Table Key Downstream Customer in Hospital Pharmacy
Figure Retail Pharmacy Examples
Table Key Downstream Customer in Retail Pharmacy
Figure Online Pharmacy Examples
Table Key Downstream Customer in Online Pharmacy
Figure EMEA Sorafenib Market Size (Million USD) by Region (2012-2022)
Figure Europe Sorafenib Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Sorafenib Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Sorafenib Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Sorafenib Revenue (Million USD) Status and Forecast by Countries
Figure Africa Sorafenib Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Sorafenib Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Sorafenib Sales Volume and Growth Rate (2012-2022)
Figure EMEA Sorafenib Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Sorafenib Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Sorafenib Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Sorafenib Sales Share by Players (2012-2017)
Figure 2016 Sorafenib Sales Share by Players
Figure 2017 Sorafenib Sales Share by Players
Figure EMEA Sorafenib Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Sorafenib Revenue (Million USD) by Players (2012-2017)
Table EMEA Sorafenib Revenue Share by Players (2012-2017)
Table 2016 EMEA Sorafenib Revenue Share by Players
Table 2017 EMEA Sorafenib Revenue Share by Players
Table EMEA Sorafenib Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Sorafenib Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Sorafenib Sales Share by Type (2012-2017)
Figure Sales Market Share of Sorafenib by Type (2012-2017)
Figure EMEA Sorafenib Sales Market Share by Type (2012-2017)
Table EMEA Sorafenib Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Sorafenib Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Sorafenib by Type in 2016
Table EMEA Sorafenib Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Sorafenib Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Sorafenib Sales Share by Application (2012-2017)
Figure Sales Market Share of Sorafenib by Application (2012-2017)
Figure EMEA Sorafenib Sales Market Share by Application in 2016
Table EMEA Sorafenib Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Sorafenib Sales Share by Region (2012-2017)
Figure Sales Market Share of Sorafenib by Region (2012-2017)
Figure EMEA Sorafenib Sales Market Share in 2016
Table EMEA Sorafenib Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Sorafenib Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Sorafenib by Region (2012-2017)
Figure EMEA Sorafenib Revenue Market Share Regions in 2016
Table EMEA Sorafenib Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Sorafenib Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Sorafenib Revenue and Growth Rate (2012-2017)
Table Europe Sorafenib Sales (K Pcs) by Type (2012-2017)
Table Europe Sorafenib Market Share by Type (2012-2017)
Figure Europe Sorafenib Market Share by Type in 2016
Table Europe Sorafenib Sales (K Pcs) by Application (2012-2017)
Table Europe Sorafenib Market Share by Application (2012-2017)
Figure Europe Sorafenib Market Share by Application in 2016
Table Europe Sorafenib Sales (K Pcs) by Countries (2012-2017)
Table Europe Sorafenib Sales Market Share by Countries (2012-2017)
Figure Europe Sorafenib Sales Market Share by Countries (2012-2017)
Figure Europe Sorafenib Sales Market Share by Countries in 2016
Table Europe Sorafenib Revenue (Million USD) by Countries (2012-2017)
Table Europe Sorafenib Revenue Market Share by Countries (2012-2017)
Figure Europe Sorafenib Revenue Market Share by Countries (2012-2017)
Figure Europe Sorafenib Revenue Market Share by Countries in 2016
Figure Germany Sorafenib Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Sorafenib Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Sorafenib Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Sorafenib Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Sorafenib Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Sorafenib Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Sorafenib Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Sorafenib Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Sorafenib Sales (K Pcs) by Type (2012-2017)
Table Middle East Sorafenib Market Share by Type (2012-2017)
Figure Middle East Sorafenib Market Share by Type (2012-2017)
Table Middle East Sorafenib Sales (K Pcs) by Applications (2012-2017)
Table Middle East Sorafenib Market Share by Applications (2012-2017)
Figure Middle East Sorafenib Sales Market Share by Application in 2016
Table Middle East Sorafenib Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Sorafenib Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Sorafenib Sales Volume Market Share by Countries in 2016
Table Middle East Sorafenib Revenue (Million USD) by Countries (2012-2017)
Table Middle East Sorafenib Revenue Market Share by Countries (2012-2017)
Figure Middle East Sorafenib Revenue Market Share by Countries (2012-2017)
Figure Middle East Sorafenib Revenue Market Share by Countries in 2016
Figure Saudi Arabia Sorafenib Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Sorafenib Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Sorafenib Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Sorafenib Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Sorafenib Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Sorafenib Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Sorafenib Sales (K Pcs) by Type (2012-2017)
Table Africa Sorafenib Sales Market Share by Type (2012-2017)
Figure Africa Sorafenib Sales Market Share by Type (2012-2017)
Figure Africa Sorafenib Sales Market Share by Type in 2016
Table Africa Sorafenib Sales (K Pcs) by Application (2012-2017)
Table Africa Sorafenib Sales Market Share by Application (2012-2017)
Figure Africa Sorafenib Sales Market Share by Application (2012-2017)
Table Africa Sorafenib Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Sorafenib Sales Market Share by Countries (2012-2017)
Figure Africa Sorafenib Sales Market Share by Countries (2012-2017)
Figure Africa Sorafenib Sales Market Share by Countries in 2016
Table Africa Sorafenib Revenue (Million USD) by Countries (2012-2017)
Table Africa Sorafenib Revenue Market Share by Countries (2012-2017)
Figure Africa Sorafenib Revenue Market Share by Countries (2012-2017)
Figure Africa Sorafenib Revenue Market Share by Countries in 2016
Figure South Africa Sorafenib Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Sorafenib Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Sorafenib Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Sorafenib Sales (K Pcs) and Growth Rate (2012-2017)
Table Pfizer Sorafenib Basic Information List
Table Pfizer Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Sorafenib Sales (K Pcs) and Growth Rate (2012-2017)
Figure Pfizer Sorafenib Sales Market Share in EMEA (2012-2017)
Figure Pfizer Sorafenib Revenue Market Share in EMEA (2012-2017)
Table Allergan Sorafenib Basic Information List
Table Allergan Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Allergan Sorafenib Sales (K Pcs) and Growth Rate (2012-2017)
Figure Allergan Sorafenib Sales Market Share in EMEA (2012-2017)
Figure Allergan Sorafenib Revenue Market Share in EMEA (2012-2017)
Table Alnylam Pharmaceuticals Sorafenib Basic Information List
Table Alnylam Pharmaceuticals Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Alnylam Pharmaceuticals Sorafenib Sales (K Pcs) and Growth Rate (2012-2017)
Figure Alnylam Pharmaceuticals Sorafenib Sales Market Share in EMEA (2012-2017)
Figure Alnylam Pharmaceuticals Sorafenib Revenue Market Share in EMEA (2012-2017)
Table Acceleron Pharma Sorafenib Basic Information List
Table Acceleron Pharma Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Acceleron Pharma Sorafenib Sales (K Pcs) and Growth Rate (2012-2017)
Figure Acceleron Pharma Sorafenib Sales Market Share in EMEA (2012-2017)
Figure Acceleron Pharma Sorafenib Revenue Market Share in EMEA (2012-2017)
Table Biocon Sorafenib Basic Information List
Table Biocon Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biocon Sorafenib Sales (K Pcs) and Growth Rate (2012-2017)
Figure Biocon Sorafenib Sales Market Share in EMEA (2012-2017)
Figure Biocon Sorafenib Revenue Market Share in EMEA (2012-2017)
Table Bionomics Sorafenib Basic Information List
Table Bionomics Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bionomics Sorafenib Sales (K Pcs) and Growth Rate (2012-2017)
Figure Bionomics Sorafenib Sales Market Share in EMEA (2012-2017)
Figure Bionomics Sorafenib Revenue Market Share in EMEA (2012-2017)
Table CASI Pharmaceuticals Sorafenib Basic Information List
Table CASI Pharmaceuticals Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure CASI Pharmaceuticals Sorafenib Sales (K Pcs) and Growth Rate (2012-2017)
Figure CASI Pharmaceuticals Sorafenib Sales Market Share in EMEA (2012-2017)
Figure CASI Pharmaceuticals Sorafenib Revenue Market Share in EMEA (2012-2017)
Table Celgene Corporation Sorafenib Basic Information List
Table Celgene Corporation Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Celgene Corporation Sorafenib Sales (K Pcs) and Growth Rate (2012-2017)
Figure Celgene Corporation Sorafenib Sales Market Share in EMEA (2012-2017)
Figure Celgene Corporation Sorafenib Revenue Market Share in EMEA (2012-2017)
Table Enzon Pharmaceuticals Sorafenib Basic Information List
Table Enzon Pharmaceuticals Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Enzon Pharmaceuticals Sorafenib Sales (K Pcs) and Growth Rate (2012-2017)
Figure Enzon Pharmaceuticals Sorafenib Sales Market Share in EMEA (2012-2017)
Figure Enzon Pharmaceuticals Sorafenib Revenue Market Share in EMEA (2012-2017)
Table Five Prime Therapeutics Sorafenib Basic Information List
Table Five Prime Therapeutics Sorafenib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Five Prime Therapeutics Sorafenib Sales (K Pcs) and Growth Rate (2012-2017)
Figure Five Prime Therapeutics Sorafenib Sales Market Share in EMEA (2012-2017)
Figure Five Prime Therapeutics Sorafenib Revenue Market Share in EMEA (2012-2017)
Table Fujifilm Kyowa Kirin Biologics Sorafenib Basic Information List
Table Genentech Sorafenib Basic Information List
Table Genexine Sorafenib Basic Information List
Table Hetero Drugs Sorafenib Basic Information List
Table ImClone Systems Sorafenib Basic Information List
Table Intas Pharmaceuticals Sorafenib Basic Information List
Table Levolta Pharmaceuticals Sorafenib Basic Information List
Table Mabtech Sorafenib Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Sorafenib
Figure Manufacturing Process Analysis of Sorafenib
Figure Sorafenib Industrial Chain Analysis
Table Raw Materials Sources of Sorafenib Major Manufacturers in 2016
Table Major Buyers of Sorafenib
Table Distributors/Traders List
Figure EMEA Sorafenib Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Sorafenib Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Sorafenib Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Sorafenib Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Sorafenib Sales Market Share Forecast by Region (2017-2022)
Table EMEA Sorafenib Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Sorafenib Revenue Market Share Forecast by Region (2017-2022)
Table Europe Sorafenib Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Sorafenib Sales Market Share Forecast by Countries (2017-2022)
Table Europe Sorafenib Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Sorafenib Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Sorafenib Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Sorafenib Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Sorafenib Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Sorafenib Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Sorafenib Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Sorafenib Sales Market Share Forecast by Countries (2017-2022)
Table Africa Sorafenib Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Sorafenib Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Sorafenib Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Sorafenib Sales Market Share Forecast by Type (2017-2022)
Table EMEA Sorafenib Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Sorafenib Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources